Maplirpacept: a CD47 decoy receptor with minimal red blood cell binding and robust anti-tumor efficacy
IntroductionCD47 is highly expressed on cancer cells and triggers an anti-phagocytic “don’t eat me” signal when bound by the inhibitory signal regulatory protein α (SIRPα) expressed on macrophages. While CD47 blockade can mitigate tumor growth, many CD…